Shyamal Majumdar &Amp;Amp; Abhineet Kumar

Stories by Shyamal Majumdar &Amp;Amp; Abhineet Kumar

Mid-career burnout: Don't let office blues ruin your life

Mid-career burnout: Don't let office blues ruin your life

Rediff.com   3 Apr 2018

A common mistake people make is to believe there is nothing they can do about it

How best to restore India's toxic banks to health

How best to restore India's toxic banks to health

Rediff.com   24 Mar 2018

The government must set up a Bank Investment Company to shrink its role in PSBs, if we are serious about tackling the two persistent issues - lax corporate governance practices and discretionary decision-making, says Shyamal Majumdar.

Why Dr Reddy's expects FY19 to be stronger and richer

Why Dr Reddy's expects FY19 to be stronger and richer

Rediff.com   6 Mar 2018

The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015

How 'forex specialist' Shetty retired as deputy manager at PNB

How 'forex specialist' Shetty retired as deputy manager at PNB

Rediff.com   6 Mar 2018

A large number of public sector bank employees, as a matter of routine, do not "take" promotions so that they are not transferred out of their hometowns. The eastern region is famous for this, but it is a common practice everywhere, says Shyamal Majumdar.

Aurbindo Pharma ranks 2nd among Indian's pharma cos

Aurbindo Pharma ranks 2nd among Indian's pharma cos

Rediff.com   20 Feb 2018

With sales of over Rs 12,240 crore in nine months of the current financial year, it is ahead of Rs 11,580 crore recorded by Lupin but behind Sun Pharma, which reported Rs 19,350 crore sales.

Taj takes another U-turn on branding

Taj takes another U-turn on branding

Rediff.com   20 Feb 2018

The multi-brand strategy could drive profitability to a 25% profit margin in the next five years from 17% now.

David vs Goliath: How Wockhardt plans to beat global challenge

David vs Goliath: How Wockhardt plans to beat global challenge

Rediff.com   22 Jan 2018

Only 11 antibiotics in clinical trials have received qualified infectious disease product status from the US FDA, of which five are Wockhardt's drugs.

Can Reliance be among the world's top 20 companies?

Can Reliance be among the world's top 20 companies?

Rediff.com   11 Jan 2018

The firm would require it to more than triple its CAGR of revenue to 18.5% for the next decade from 6%

Bankruptcy will influence M&A trend in 2018

Bankruptcy will influence M&A trend in 2018

Rediff.com   2 Jan 2018

Banks have Rs 10 trillion in stressed assets - Rs 7.8 trillion of bad loans and Rs 2.2 trillion of restructured ones.

Gujarat's won, now Mr PM, please fix our biggest problem

Gujarat's won, now Mr PM, please fix our biggest problem

Rediff.com   18 Dec 2017

43 months after Modi's election promise that his government would create 10 million jobs, the reality does not paint a pretty picture, warns Shyamal Majumdar.

Mental health disorders: India's invisible epidemic

Mental health disorders: India's invisible epidemic

Rediff.com   16 Dec 2017

And the way to a cure begins with conversation.

How India narrowly escaped a health crisis

How India narrowly escaped a health crisis

Rediff.com   5 Dec 2017

The Philippines launches probe after Sanofi reveals WHO-approved dengvaxia - a dengue vaccine - aggravates symptoms in some cases.

Why retailers are betting big on small towns

Why retailers are betting big on small towns

Rediff.com   5 Dec 2017

The expansion into smaller towns is coming at a time when the online retail space has not only seen consolidation but is actually looking to collaborate with physical stores. Abhineet Kumar reports.

What IndiGo needs to do to restore its image

What IndiGo needs to do to restore its image

Rediff.com   25 Nov 2017

IndiGo clearly needs to refresh its HR and training manual, says Shyamal Majumdar.

This is why Godrej is a big name in India's real estate sector

This is why Godrej is a big name in India's real estate sector

Rediff.com   21 Nov 2017

In the quarter ended September 30, the Pirojsha Godrej-led firm recorded Rs 492 crore net sales, up 49% year-on-year

Meet India's highest paid CEO

Meet India's highest paid CEO

Rediff.com   25 Oct 2017

His compensation in FY17 was more than the combined salaries of the entire boards of TCS, Wipro and Infosys. 'I am a self-made man from a very modest background,' Tech Mahindra's CEO C P Gurnani tells Shyamal Majumdar.

How Shoppers Stop pulled itself back

How Shoppers Stop pulled itself back

Rediff.com   23 Oct 2017

Shoppers Stop returns to its core business after divestments. The retailer plans growth through web and private labels.

Indian execs paying a high price for life in the fast lane

Indian execs paying a high price for life in the fast lane

Rediff.com   17 Oct 2017

Experts say one in every four mental health problems is due to depression and anxiety at the workplace.

Nachiket Mor has his heart in the right place

Nachiket Mor has his heart in the right place

Rediff.com   9 Oct 2017

After a 25-year stint at ICICI Bank, Mor suddenly quit as he wanted to add more value in the bigger areas of health care and financial inclusion.

Will Tatas and Ambanis succeed where Birla failed?

Will Tatas and Ambanis succeed where Birla failed?

Rediff.com   3 Oct 2017

As India's online population crosses 450 million, e-commerce ventures are trying to grab a pie of online sales estimated to hit $48 billion by 2020.